KalVista Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
KalVista Pharmaceuticals Inc
CIK #0001348911, 0001678087
EDGAR Form CIK 2011 - 2026
10-K [0001348911]
10-Q [0001348911]
3 [0001348911]
4 [0001348911]
8-K [0001348911]
D [0001348911]
SC 13D [0001348911]
SC 13G [0001348911]
SC 13D [0001678087]
Form 13D/13G Filer Form 13D/13G Subject Filed
Glazer Capital LLC KalVista Pharmaceuticals Inc [2026-06-10]
SilverArc Capital Management LLC KalVista Pharmaceuticals Inc [2026-05-13]
Point72 Asset Management LP KalVista Pharmaceuticals Inc [2026-01-12]
Millennium Management LLC KalVista Pharmaceuticals Inc [2025-11-10]
Vestal Point Capital LP KalVista Pharmaceuticals Inc [2024-11-14]
Capital World Investors KalVista Pharmaceuticals Inc [2024-11-13]
Adage Capital Partners GP LLC KalVista Pharmaceuticals Inc [2024-02-26]
Vanguard Group Inc KalVista Pharmaceuticals Inc [2024-02-13]
Saturn V Capital Management LP KalVista Pharmaceuticals Inc [2024-02-12]
BlackRock Inc KalVista Pharmaceuticals Inc [2024-01-29]
View All
Form 3/4/5 Subject 2011 - 2026
Palleiko Benjamin L
KalVista Pharmaceuticals Inc
Sweeny Nicole
Yea Christopher
Unkart Edward W
Pereira Brian JG
Treanor Patrick
Arif Bilal
Sensenig Bethany
Reid Laurence
Stuart Nancy
Audhya Paul K
Piekos Brian
Fairey William
Shah Nimish P
VHCP Management EG LLC
VHCP Management III LLC
Venrock Healthcare Capital Partners EG LP
Koh Bong Y
Venrock Healthcare Capital Partners III LP
VHCP Co-Investment Holdings III LLC
Feener Edward P
Crockett Thomas Andrew
Cha Albert
Smith Michael David
Edwards Martin
Soland Daniel B
Maetzel Andreas
Oronsky Arnold L
SV Life Sciences Fund IV Strategic Partners L P
SV Life Sciences Fund IV GP LP
SV Life Sciences Fund IV LP
SVLSF IV LLC
VHCP Co-Investment Holdings II LLC
VHCP Management II LLC
Venrock Healthcare Capital Partners II LP
Aldrich Richard
Kolchinsky Peter
RA Capital Management LP
Shah Rajeev M
Novo Holdings A/S
Resnick Joshua
Renzi David
RA Capital Healthcare Fund LP
Maroney Marcee
Basta Steven L
Saul David Joseph
Ramiya Premchandran
Gravett David M
McKune John
Zadno Reza
Lewis Hayley
Clapper David M
Katkin Keith
Vivo Ventures VI Affiilates Fund LP
Vivo Ventures VI LLC
Vivo Ventures Fund VI LP
Kjellson Nina S
Gianos Philip T
Nasr Khaled
Holmes W Stephen
Pepper Douglas A
Kliman Gilbert H
InterWest Venture Management Company
InterWest Venture Management Company
Cleveland Bruce A
ACP IV LP
ACMP IV LLC
Janney Daniel
Nohra Guy P
White Thomas Michael
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-26 Sell 21,386 $17.76 379,815
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-26 Sell 15,417 $18.82 290,148
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-26 Sell 3,183 $19.12 60,859
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-25 Sell 174,485 $16.95 2,957,521
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-25 Sell 160 $17.53 2,805
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-09 Sell 6,693 $16.08 107,623
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-06 Option exercise 15,625
KalVista Pharmaceuticals Inc KALV
Restricted Stock Unit · derivative
2026-03-06 Option exercise 15,625 $0.00
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-02-23 Sell 10,034 $15.57 156,229
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-02-23 Sell 3,975 $15.57 61,891
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-02-23 Sell 5,354 $15.57 83,362
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-02-23 Sell 1,767 $15.57 27,512
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-02-23 Sell 4,347 $15.57 67,683
KalVista Pharmaceuticals Inc KALV
Restricted Stock Unit · derivative
2026-02-22 Option exercise 3,125 $0.00
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-02-22 Option exercise 5,000
KalVista Pharmaceuticals Inc KALV
Restricted Stock Unit · derivative
2026-02-22 Option exercise 5,000 $0.00
KalVista Pharmaceuticals Inc KALV
Restricted Stock Unit · derivative
2026-02-22 Option exercise 5,000 $0.00
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-02-22 Option exercise 5,000
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-02-22 Option exercise 3,125
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-02-21 Option exercise 6,250
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com